Search
Now showing items 1-1 of 1
Chronic ethanol use in alcoholic beverages by HIV-infected patients affects the therapeutic window of stavudine, lamivudine and nevirapine during the 9-month follow-up period: using chronic alcohol-use biomarkers
(Journal of Basic and Clinical Physiology and Pharmacology, 2013)
Background: Chronic ethanol use is a global problem
including among HIV-infected patients on stavudine/
lamivudine/nevirapine (d4T/3TC/NVP) regimen. The
study determined the effect of chronic ethanol use on the
therapeutic ...